AI-generated summary
The authors report a randomised, within-wound controlled trial in 15 client-owned dogs and cats comparing fluorescence biomodulation added to standard wound care with untreated control portions of the same wounds. They found no statistically significant differences in wound area reduction, qualitative healing scores, histology or immunohistochemistry, with heterogeneous responses across wounds.
- Participants
- 15
- Who or what was studied
- Client-owned dogs and cats with open wounds of various aetiologies
- Limits stated in the abstract
- Small sample of 15 animals, exploratory post hoc analyses that were not statistically significant, and a heterogeneous response across wounds.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
Background
Open wounds are a common clinical problem in small animal practice and are associated with delayed healing, infection, and increased treatment burden. Fluorescence biomodulation (FB), a form of photobiomodulation therapy (PBMT), has shown benefits in several dermatological conditions; however, its efficacy in veterinary open wounds remains unclear.
Objectives
To evaluate the effect of FB as an adjunct to standardised wound management on healing progression in open wounds in dogs and cats using a prospective, randomised, within-wound controlled clinical trial.
Methods
Fifteen client-owned dogs and cats with open wounds of various aetiologies were enrolled. Each wound was divided into two portions: one treated weekly with FB and one untreated control, both receiving standardised wound care based on the TIME framework. Quantitative wound area reduction was assessed by serial planimetric measurements. Qualitative healing parameters were scored weekly by two blinded observers, and semiquantitative histological and immunohistochemical evaluation was performed in surgically treated cases. Paired statistical analyses were used. A time-integrated analysis based on the area under the curve (AUC) of normalised wound area was performed to assess healing kinetics.
Results
No statistically significant differences were observed between treated and control portions for percentage wound area reduction, qualitative healing scores, or semiquantitative histological and immunohistochemical outcomes. Quantitative planimetry showed a heterogeneous response, with seven wounds favouring the treated portion, six favouring the control portion, and two showing equivalent outcomes. Exploratory post hoc time-integrated analyses suggested a trend toward earlier wound area reduction in some cases, particularly when treatment was initiated early; however, these findings were not statistically significant. Complete wound closure during follow-up did not differ significantly between portions. Histological analysis showed only small numerical differences between portions, with no statistically significant differences in collagen deposition, angiogenesis, inflammatory response, fibroblast proliferation, or CD31 and Ki67 expression.
Conclusion
Under the conditions tested, FB did not demonstrate a consistent measurable advantage over standardised wound management in open wounds in dogs and cats. Any potential clinical benefit appeared modest and possibly limited to selected wound presentations. Further prospectively stratified studies focused on healing speed and readiness for closure are warranted.
Abstract reproduced under the CC BY license. Source: PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation therapy, Photobiomodulation, Angiogenesis, Collagen. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.